GSC invests in GenXys

Green Shield Canada has invested in GenXys, a Vancouver, British Columbia-based developer of precision prescribing software and pharmacogenetics testing.

27 May 2020•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles